248 related articles for article (PubMed ID: 26921287)
1. Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.
Joshi N; Kopec AK; Ray JL; Cline-Fedewa H; Nawabi A; Schmitt T; Nault R; Zacharewski TR; Rockwell CE; Flick MJ; Luyendyk JP
Blood; 2016 Jun; 127(22):2751-62. PubMed ID: 26921287
[TBL] [Abstract][Full Text] [Related]
2. Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte α
Kopec AK; Joshi N; Cline-Fedewa H; Wojcicki AV; Ray JL; Sullivan BP; Froehlich JE; Johnson BF; Flick MJ; Luyendyk JP
J Hepatol; 2017 Apr; 66(4):787-797. PubMed ID: 27965156
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis.
Joshi N; Ray JL; Kopec AK; Luyendyk JP
J Biochem Mol Toxicol; 2017 Jan; 31(1):1-7. PubMed ID: 27605088
[TBL] [Abstract][Full Text] [Related]
4. Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice.
Joshi N; Kopec AK; O'Brien KM; Towery KL; Cline-Fedewa H; Williams KJ; Copple BL; Flick MJ; Luyendyk JP
J Thromb Haemost; 2015 Jan; 13(1):57-71. PubMed ID: 25353084
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
Joshi N; Kopec AK; Cline-Fedewa H; Luyendyk JP
Toxicology; 2017 Feb; 377():73-80. PubMed ID: 28049044
[TBL] [Abstract][Full Text] [Related]
6. The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
Joshi N; Kopec AK; Towery K; Williams KJ; Luyendyk JP
J Pharmacol Exp Ther; 2014 Jun; 349(3):383-92. PubMed ID: 24633426
[TBL] [Abstract][Full Text] [Related]
7. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.
Flick MJ; LaJeunesse CM; Talmage KE; Witte DP; Palumbo JS; Pinkerton MD; Thornton S; Degen JL
J Clin Invest; 2007 Nov; 117(11):3224-35. PubMed ID: 17932565
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
Luyendyk JP; Kassel KM; Allen K; Guo GL; Li G; Cantor GH; Copple BL
Am J Pathol; 2011 Mar; 178(3):1117-25. PubMed ID: 21356363
[TBL] [Abstract][Full Text] [Related]
9. Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice.
Sullivan BP; Cui W; Copple BL; Luyendyk JP
Toxicol Sci; 2012 Mar; 126(1):267-74. PubMed ID: 22094456
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor.
Vidal B; Ardite E; Suelves M; Ruiz-Bonilla V; Janué A; Flick MJ; Degen JL; Serrano AL; Muñoz-Cánoves P
Hum Mol Genet; 2012 May; 21(9):1989-2004. PubMed ID: 22381526
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo.
Flick MJ; Du X; Witte DP; Jirousková M; Soloviev DA; Busuttil SJ; Plow EF; Degen JL
J Clin Invest; 2004 Jun; 113(11):1596-606. PubMed ID: 15173886
[TBL] [Abstract][Full Text] [Related]
12. Elimination of the fibrinogen integrin α
Nasimuzzaman M; Arumugam PI; Mullins ES; James JM; VandenHeuvel K; Narciso MG; Shaw MA; McGraw S; Aronow BJ; Malik P
Blood Adv; 2019 May; 3(9):1519-1532. PubMed ID: 31076408
[TBL] [Abstract][Full Text] [Related]
13. Biliary epithelial cell proliferation following alpha-naphthylisothiocyanate (ANIT) treatment: relationship to bile duct obstruction.
Kossor DC; Goldstein RS; Ngo W; DeNicola DB; Leonard TB; Dulik DM; Meunier PC
Fundam Appl Toxicol; 1995 Jun; 26(1):51-62. PubMed ID: 7657062
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice.
Luyendyk JP; Cantor GH; Kirchhofer D; Mackman N; Copple BL; Wang R
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G840-9. PubMed ID: 19179621
[TBL] [Abstract][Full Text] [Related]
15. Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.
Poole LG; Pant A; Baker KS; Kopec AK; Cline-Fedewa HM; Iismaa SE; Flick MJ; Luyendyk JP
J Thromb Haemost; 2019 Jan; 17(1):113-125. PubMed ID: 30415489
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor exerts hepatoprotective effects in acute but not chronic cholestatic liver injury in mice.
Poole LG; Fournier AK; Cline-Fedewa HM; Kopec AK; Luyendyk JP; Groeneveld DJ
Toxicology; 2021 Nov; 463():152968. PubMed ID: 34619301
[TBL] [Abstract][Full Text] [Related]
17. Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury.
Luyendyk JP; Mackman N; Sullivan BP
Toxicol Sci; 2011 Jan; 119(1):233-43. PubMed ID: 20974703
[TBL] [Abstract][Full Text] [Related]
18. Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasia.
Kossor DC; Meunier PC; Dulik DM; Leonard TB; Goldstein RS
Toxicol Appl Pharmacol; 1998 Oct; 152(2):327-38. PubMed ID: 9853002
[TBL] [Abstract][Full Text] [Related]
19. Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury.
Xu J; Lee G; Wang H; Vierling JM; Maher JJ
Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G734-41. PubMed ID: 15130876
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.
Joshi N; Kopec AK; Ray JL; Luyendyk JP
Toxicology; 2016 Jul; 365():9-16. PubMed ID: 27475285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
